investordatabase.org

安富資本股份有限公司 (Affinity Capital)

affinity.com.tw Direct investor

安富資本是一家台灣投資機構,管理安富大健康一號與二號基金,投資於AI與半導體科技生態、創新醫療與生技,以及具成長潛力並走向資本市場的企業。

安富資本股份有限公司 (Affinity Capital) is a venture capital firm headquartered in 台北市, Taiwan. It invests directly in companies, from Series C and later to growth, in AI, 半導體, 生技 and 醫療器材.

“我們聚焦於創新AI科技及生命科學驅動之產業,結合全球資本市場與跨國資源配置能力,打造安富資本具國際競爭力與永續成長潛力的卓越品牌價值。”

— 安富資本股份有限公司 (Affinity Capital), own website
Layer
Direct investor
Type
Venture capital
Stage
Series C+ – Growth
Headquarters
台北市, Taiwan
Sectors
AI, 半導體, 生技, 醫療器材, 新藥, 軟體

Team, as 安富資本股份有限公司 (Affinity Capital) publishes it

  • 林羣 Andrew Lin 董事長 / 管理合夥人
  • 蔡政哲 Jeffrey Tsai 資深合夥人
  • 魏寶生 Mark Wei 資深合夥人
  • 程淑芬 Sophia Cheng 資深合夥人
  • 馬瑜明 Vincent Ma 合夥人
  • 程守真 James Cheng 合夥人
  • 林庭寬 Martin Lin 營運長 / 投資部副總
  • 賴雅暐 Ingrid Lai 財務長 / 投資部副總
  • 葉育瀅 Annie Yeh 研究部副總 / 投資部副總
  • 匡小琪 Amanda Kuang 投資部經理
  • 呂鈺萱 Sheryl Lu 投資部副理

Names and roles exactly as listed on affinity.com.tw. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page 安富資本股份有限公司 (Affinity Capital) publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 16414 · added 2026-10-26 · link last verified 2026-10-26 · confidence high

Similar investors

Listed under